“MEASURED - REAL VALUES OF INTRAOCULAR TENSION, 24 H AFTER THE APPLICATION OF BROLUCIZUMAB INTRAVITREAL INJECTION IN PATIENTS WITH wAMD”, mij, vol. 3, no. 3, pp. 23–26, Sep. 2024, doi: 10.35120/medisij030323h.